TREATMENT REGIME AND BIOACTIVE RETENTION IN NONI EXTRACT ENCAPSULATED LIQUID APPLYING HOMOGENIZED SUSPENSION APPROACH

Tóm tắt

Microencapsulated bioactive compounds from noni fruit (Morinda citrifolia) offer diverse health benefits. This study aimed to optimize liquid encapsulation of noni extract using a homogenized suspension approach. Parameters such as shell formulation, homogenization speed, and pasteurization were scrutinized to obtain suspension stability and achieve better bioactive retentions concerning total phenolics (TPC), total flavonoids (TFC), and total saponins (TSC). Microcapsule size and analytical characteristics of the resulting microencapsulated solution were assessed, including bioactive degradation kinetics. The findings examined that the microencapsulated solution combining maltodextrin and gum arabic exhibited the highest stability and yielded the greatest TPC, TFC, and TSC contents. Optimal homogenized suspension was determined and pasteurized for storage in a refrigerator at 10°C for 10 months, maintaining encapsulation efficiency of TPC, TFC, and TSC at 82.2%, 87.6%, and 85.9%, respectively. A robust shelf life underscored its quality and longevity, which is potential for studies on scalability and further applications